2022 SITC 1258 PBMC humanized mouse model with clinical relevance in assessing the safety profile of 4-1BB agonists utomilumab and urelumab Published Date November 10, 2022 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen